Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Status
Recruiting
Trial Recruitment Size
144
Trial Sponsor
Trial Collaborator
Clinical Trial Start Date
July 28, 2020
Primary Completion Date
September 1, 2020
Study Completion Date
August 1, 2021
Clinical Trial Study Type
Interventional
Interventional Trial Purpose
Prevention0
Intervention Type
Biological
Other0
Intervention Name
BNT162b10
Placebo0
Interventional Trial Phase
Phase 1
Official Name
Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (BNT162b1) in Chinese Healthy Subjects: A Phase I, Randomized, Placebo-controlled, Observer-blind Study0
Last Updated
September 18, 2023
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Triple0
Masked Party
Participant0
Outcomes Assessor0
Investigator0
No article content yet.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
